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Abstract
Background: How to meaningfully partner with patients as data analysts remains ob-
scure. A process evaluation of the ‘Improving the Safety and Continuity Of Medicines 
management at care Transitions’ (ISCOMAT) cluster randomised control trial of an 
intervention for improving medicines use for people living with heart failure is being 
conducted. The intervention includes patient held information on heart medicines 
and care, enhanced communication between hospital and community pharmacists, 
and increased engagement of community pharmacists with patient care post- hospital 
discharge. ISCOMAT patients living with heart failure were interviewed about expe-
riences with the intervention. We sought to gain insights from patients on data col-
lected to enhance our understanding of experiences with the intervention.
Objective: To develop a method for involving patients as analysts of qualitative data 
in a process evaluation.
Design: Patients and researchers co- analysed qualitative data. A framework method 
was applied involving; familiarisation, coding, developing an analytical framework 
and interpretation. The process was facilitated through home working and a work-
shop with a training component.
Results: The co- designed framework enabled researchers to map all further patient 
interview data. Patients' specialist knowledge enhanced understanding of how the 
ISCOMAT intervention can be best implemented.
Conclusions: Patients’ unique experiences can enhance validity and rigour in data 
analysis through sharing their interpretations of qualitative data. The involvement 
process is crucial in elucidating knowledge and avoiding tokenism. As analysts, 
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1  | INTRODUC TION
Patients are increasingly involved in health research. Research 
funders both require and support patient public involvement (PPI) 
in research.1,2 While patients are involved in phases of research, 
from conception through to dissemination,3 only a limited number 
of studies involve patients beyond an advisory capacity and as co- 
researchers.4- 6 Where co- researcher studies have been conducted, 
the benefits to science have been under- reported. The scientific 
value of patient involvement needs to be highlighted to avoid a 
tokenistic approach.7 Patients can add 'experiential knowledge', 
personal insights of how individuals cope and live with illness or dis-
ability. PPI in data analysis could improve the relevance, focus and 
real- world acceptability of health research;8 however, the process 
for this remains obscure.
'Equity' has been a key concern underpinning approaches to PPI 
in health research.9 PPI has the potential to empower individuals and 
communities to have a significant role in shaping health and social 
care research. For example, participatory research has sought to 
redress power imbalances for indigenous minority populations. By 
democratising health and social care research, we can realise its po-
tential to provide maximum health and social benefits.2,10 The gener-
ation of shared 'knowledge spaces' where patients and researchers 
with different perspectives can interact could form a vital part of 
a co- analysis process.5,11 Patients require 'appropriate' knowledge 
and skills to effectively carry out their role.12 Training that is flexi-
ble according to skills, interests, topic and project type is important 
in ensuring meaningful PPI.13 Training would need to avoid ‘profes-
sionalising’ patient viewpoints, enabling authentic patient views to 
enhance an understanding of research as opposed to encouraging 
views from an academic perspective. 14 Practical considerations 
must be considered, such as the ability to travel to attend meetings.15
Patients’ capacity for involvement may vary, and projects have 
resource limitations.9 Given these considerations, how can patients 
be meaningfully involved as analysts to enhance scientific value? We 
sought to involve patients as analysts for our process evaluation of 
the Improving the Safety and Continuity Of Medicines management 
at care Transitions (ISCOMAT) cluster randomised control trial. The 
co- designed ISCOMAT Medicines at Transitions Intervention (MaTI) 
seeks to make best use of medicines and reduce harm through: pa-
tient held information; enhanced communication between hospital 
and the patient's community pharmacist; and increased engagement 
of the community pharmacist post- hospital discharge.16 The process 
evaluation collected interview data from ISCOMAT patients on their 
experiences of the intervention. We aimed to develop a method of 
meaningfully involving patients as analysts of patient interviews in a 
process evaluation.
2  | METHODS
2.1 | The ISCOMAT process evaluation
The ISCOMAT programme began in 2016 and involves four work 
packages to develop and test an intervention in a cluster randomised 
control trial, to improve medicines management for patients trans-
ferring from hospital to community. The experience- based co- 
designed intervention involves the use of patient held information, 
enhanced communication between the hospital and the patients' 
community pharmacists and increased engagement of primary care 
staff after discharge for heart failure patients.17 Further detail on 
the intervention and results will be provided in later papers. The 
ISCOMAT process evaluation seeks to inform interpretation of the 
trial findings, inform implementation of the intervention on a wider 
scale and aid dissemination of the intervention. The process evalua-
tion involves collation of multiple sources of data, such as field notes 
of hospital observations and interviews with health professionals 
and patients from six research sites. Two researchers interviewed 
20 patients across England who live with heart failure to understand 
their experiences of the intervention. Further details of the process 
evaluation are published in a protocol paper.18 The researchers in-
vited the ISCOMAT patient- led steering group (PLSG) to partner 
with researchers in co- analysing these patient interviews. Figure 1 
illustrates PLSG involvement across the four work packages of 
ISCOMAT.
2.2 | The analysis team
The analysis team were two researchers, four wider process evalu-
ation team members and five patients who were members of the 
PLSG. One patient took part in the early phases but was unable to 
continue due to deteriorating ill health. Patients were identified and 
recruited through local networks or following co- design groups in 
work package two where they subsequently agreed to join the PLSG. 
Four members were living with heart failure and one was a carer. 
Two patients had degree- level education while others had diploma- 
level education. Two patients were in full- time employment. One 
patients gain an appreciation of research processes, building trust between research-
ers and patients. Group dynamics and involving patients throughout the whole re-
search process are important considerations.
K E Y W O R D S
patient participation, qualitative research, research design
     |  3POWELL Et aL.
additional patient who later joined the PLSG was involved in the later 
phase of interpretation only. Ages ranged from 32 to 84. Most ana-
lysts were male with one female in the group. Patients’ experience in 
research prior to ISCOMAT was varied with some being involved in 
other projects. None had been involved in qualitative data analysis. 
The two researchers facilitating the meeting had previous experi-
ence with PPI and conducting qualitative research.
The ‘patient analysts’ (PLSG involved in analysis) were involved in 
ISCOMAT primarily in an advisory capacity from inception to present 
trial phase. Patients’ analysts developed the interview topic guide, 
although they were unable to recall specific details. PLSG meetings 
are held quarterly, with on- going communication between research-
ers and PLSG members through phone and email. Interactions are 
research focused and social, helping the group to build strong rela-
tionships. This was the first time patients were involved in qualita-
tive data analysis in ISCOMAT or any other capacity. One training 
session was provided as part of the analysis process. No other train-
ing had occurred prior to the PLSG becoming analysts.
2.3 | Qualitative analysis method
A framework approach to qualitative data analysis was applied. 
Framework analysis, originally, created by Jane Ritchie and Liz 
Spencer,19 is a frequently used qualitative analysis method in UK 
health research.20 The framework approach involves identifying a 
framework, indexing, charting, and mapping and interpretation.19 
Gale et al20 later developed seven key steps to carry out these tasks, 
‘Step one Transcription', creating an audio and verbatim transcript; 
'Step two Familiarisation with the interview', reading and reflect-
ing on a full interview transcript; 'Step three Coding', rereading 
the transcript and applying labels to important phrases; 'Step four 
Developing a working analytical framework', the team agrees on a set 
of codes for all subsequent transcripts; 'Step five Applying the ana-
lytical framework', indexing using existing coding; 'Step six Charting 
data into a framework matrix', summarising data from categories into 
a matrix and 'Step seven Interpreting the data', an iterative process 
including exploring connections between categories and interrogat-
ing theories. The process recommends the involvement of lay mem-
bers in the analysis process yet does not provide detailed guidance 
on how to accomplish this.20
Our analysis occurred alongside data collection. The first five 
interview transcripts (of a final 20) were selected based on a range 
of intervention sites, gender, age, length of diagnosis and fidelity 
to intervention. The five patient analysts were given one unique 
anonymised transcript. Alongside the transcript, patient analysts 
were instructed how to familiarise themselves with qualitative data, 
involving reading interviews and noting in the margin anything of 
F I G U R E  1   ISCOMAT Work packages and PLSG activities
Work package 1 - Mapping a cardiology medicines 
management pathway
Work package 2 – Experience Based Co-designing 
the ISCOMAT medicines management intervention 
(Patient centred communication package & 
medicines transition toolkit) with patients and 
clinicians
Work package 3 - Development & feasibility testing  
of the ISCOMAT medicines management 
intervention
Work package 4 – Cluster randomised control trial 
and process evaluation of ISCOMAT medicines 
management intervention
PLSG activities Work package 1 and Work package 2
-Advised on patient recruitment including design of patient 
leaflets and consent forms
-Assisted in the development of the patient trigger film
-Central role in Experience Based Co-design and co 
facilitated the joint event for staff and patients
-Patient Summit meeting
PLSG activities Work package 3 and Work package 4
-Advised on patient recruitment for feasibility, co-produced 
‘Patient experience surveys’ for Work package 3
-Data analysts for process evaluation patient interviews  
-Feedback on results from Work package 3 
Additional PLSG activities related to ISCOMAT
-Regular attendance at management meetings
-Advised PhD students
-Co-edited newsletters for patients
-Provided insights on medicines
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interest concerning the intervention only. An example annotated 
transcript was provided. Patients were asked to bring and prepare 
a summary of their transcript at an analysis workshop. Framework 
analysis was selected as an appropriate method for involving pa-
tients. Evidence for a particular qualitative method, involving pa-
tients as analysts and for use in evaluating a health intervention, 
was limited. However, Framework analysis is known for its strengths 
in facilitating the involvement of less experienced researchers, and 
involving multiple individuals at multiple stages.20 Developing a 
process of integrating patients' expertise with Framework analysis 
could improve validity and rigour.
Reflections on the data analysis process were supported through 
feedback forms, on- going discussions, an audio recording of the 
workshop, as well as authoring this paper. Feedback forms enabled 
PLSG analysts to reflect on the training and workshop day consider-
ing: the most helpful parts of the workshop and training, whether to 
take part in future qualitative data analysis, key contributions made, 
and suggested improvements.
2.4 | Ethics
The ISCOMAT trial and process evaluation were approved by 
Research Ethics Committee and the UK Health Research Authority 
REC: 18/YH/0017 / IRAS: 231431. It was not necessary to gain ad-
ditional ethics committee approval specifically to involve patients 
as analysts. The PLSG had no contact with the interviewees or ac-
cess to identifiable data. The PLSG agreed to terms of reference in 
June 2017. Informed by INVOLVE guidelines,21 the terms of refer-
ence outlines that the patient's role will be to contribute to devel-
opment and be accountable to the leaders of the research project. 
Some activities include contributing to reviews and evaluations of 
the ISCOMAT programme, advising on dissemination and provid-
ing patient perspective on research deliberations. The researchers 
checked with PLSG members whether they would like to take part 
specifically as analysts. The ISCOMAT patient payment policy is in-
formed by INVOLVE guidelines22 and is as follows: £110 per meet-
ing for attending Steering/Management Group meetings, £75 for a 
F I G U R E  2   Co- analysis method and process of applying Framework analysis
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co- design event or meeting, £75 for attending other training events, 
travel costs, £20 per hour for additional work for co- analysis event. 
Patients gave their permission for this paper to be written, including 
quotes. The PLSG agreed on two members to work on this paper. 
These two co- authors (RC and AT) have made an important contri-
bution, regularly meeting with researchers (CP and HI) to revise the 
manuscript.
3  | RESULTS
We report on the process by which patient analysts were involved in 
the analysis. Figure 2 illustrates the steps in the process.
3.1 | Training
Patient analysts required appropriate knowledge and skills to com-
plete the analysis. A one- day face- to- face analysis workshop began 
with training delivered by the two researchers. Four patient analysts 
attended the workshop and training. One patient analyst was unable 
to attend on the day.
Patients were enthusiastic to engage with interview data as op-
posed to purely the method itself as they had personal interest as 
heart failure patients. As one patient highlights, ‘Being part of the 
ISCOMAT team has been one of the best experiences of my life. 
Being a patient with a long- term health condition can often make 
you introverted, but knowing that there are researchers out there 
running studies, that could potentially change patients’ lives for the 
better, makes patients want to join in and give their knowledge’.
The training provided an outline of thematic analysis, along with 
the importance of coding and how this process is undertaken. A pre-
sentation was given by the researchers. The researchers encouraged 
patient analysts to focus on the interview content, key research 
questions and the topic guide in their analysis, with sufficient op-
portunity provided for questions and discussion. The researchers 
encouraged patient analysts to engage with the content rather than 
critiquing the data collection process. This was necessary as patient 
analysts were more familiar with advising on study processes rather 
than engaging in data analysis .
The training was well- paced and helped patient analysts to de-
velop an understanding of the analysis process. One patient analyst 
felt ‘[the training] helped me understand what was expected of me 
during the analysis/workshop. It helped give me an understanding of 
what to do with the notes I had made on the transcripts and also built 
up my confidence in the subject. [The researcher] took her time and 
went through each detail answering any questions we may have had 
and stopping to check we were all following. I did not feel left behind’.
Another patient analyst felt the most important part of the work-
shop was ‘understanding what the term meant. The process is like 
squeezing a lemon. You get the last drop out of data from…what you 
might think is disconnected information’. Another patient describes 
how they were able to analyse.
‘Starting the coding was difficult at first. I was worried 
I would make a mistake, but once I got the first few 
written and logged, the task became much easier and 
more enjoyable. I found coding the transcripts really 
simple once I built up the confidence to make a start. 
I soon realised that my experience and knowledge of 
being a long- term patient made it easier for me to pick 
out sections of the transcript that felt the most valu-
able to the project’.
Thus, this new knowledge enabled patient analysts to understand 
how conclusions are drawn from interview data.
3.2 | Framework analysis of patient 
interviews process
Below, we describe the analysis process. We have adhered to the 
seven- step process in our analysis,20 developing a method to involve 
patients in earlier steps two- four, and step seven.
Step one: Transcription and anonymisation.
Researchers checked the transcripts to ensure anonymity and 
presentation requirements were accurate. Transcripts were accessi-
ble (text size, sufficient margins) to aid analysis.
Step two (a): Familiarisation with the interview: individual work 
before the workshop.
Providing one transcript allowed patients to have sufficient time 
to fully immerse themselves in an unseen interview. Researchers fa-
miliarised themselves with all transcripts given their prior research 
knowledge and skills, involvement in data collection and need for 
oversight to facilitate the workshop. One patient reflects on their 
increased confidence in the process.
‘When we received the transcripts I was nervous as to 
what was expected of us. Reading through the tran-
script I felt better about the task at hand as it was easy 
to relate to the patient’s experiences’.
Step two (b): Familiarisation with the interview: the workshop.
To give patient analysts insight into the remaining unread four tran-
scripts, each provided a verbal summary of their annotated transcripts 
to the group during the data analysis workshop held at the university. 
They described key areas of an interview and spoke about how the tran-
script resonated with their own experiences or those they have heard 
about, providing a unique contextual understanding of data. Patient an-
alysts and researchers were enthusiastic to learn about interpretations 
from other patient analysts. One patient analyst was unable to attend 
the workshop and therefore did not gain this additional insight. The re-
searchers reflected that some patient analysts appeared surprised by 
the transcripts, being unfamiliar with reading individuals’ words writ-
ten verbatim. Thus, giving patient analysts sufficient time in advance 
to read the transcript worked well in enabling familiarisation with the 
content and the organisation of interviews into verbatim transcripts.
6  |     POWELL Et aL.
Step three: Coding.
Following the discussion on transcript summaries, each group 
member coded their interview transcript. Patient analysts were 
asked to reread their transcript and focus coding in three key de-
scriptive categories relevant to interviewee experiences of the 
intervention. They were asked to write the codes on sticky notes, 
identifying the transcript and line numbers.
The process of moving from step two to coding, where specific 
data are extracted with a focus on key research aims and objectives, 
had been described in the training. The researchers provided more 
support during the coding process to ensure that patients were able 
to effectively make this transition. One action involved keeping the 
research aims and objectives in view. The researchers noticed how 
patient analysts were able to recognise barriers and facilitators to 
the ISCOMAT intervention. Being able to relate to interviewees as 
heart failure patients and carers, and their knowledge of ISCOMAT 
were key factors in facilitating this process. For example, one aim 
was to identify barriers and facilitators to experiences with commu-
nity pharmacy. In the extract below, a patient describes their lack 
of knowledge and communication with community pharmacy. The 
patient analyst was able to code this as ‘negative points re medica-
tion and pharmacy’ once they considered barriers they had when 
accessing community pharmacy themselves.
’R: Yes well I didn't even know they had a consultation room.
I: All these little rooms in the corner where you can go in and have 
a chat in privacy.
R: I mean I’d never heard of a community pharmacy office sort 
of thing. I thought, you know, all they did was dish out drugs. I 
didn't know that they actually do the conditions themselves’.
Patients analysts valued the knowledge and skills developed 
through the coding process. In written feedback one patient men-
tioned, ’with [sticky] notes, we then proceeded to flag all the parts of 
the transcripts we found the most important…It enabled me to im-
prove upon my skills of analysing…and develop the new skill of coding’. 
Through understanding and applying the newly acquired skill of cod-
ing, patient analysts had a method of communicating their interpreta-
tion of data.
Step four: Developing a working analytical framework.
The sticky notes with coding were placed on papers organised 
by the three key categories: experiences at community pharmacy, 
experience with medicines and experience with the patient held 
information. The patient analysts and researchers discussed and 
identified themes from the coding, identifying repeated ideas and 
grouping them with a common point of reference. In addition to the 
training, group working supported patient analysts understanding 
of how to move from codes to developing a thematic framework. 
For example, one theme around ‘communication’ was created as a 
barrier to experiences with the pharmacist. Sticky notes with coding 
relevant to this agreed theme were placed underneath. The example 
provided earlier of a patient coding ‘negative points re medication 
and pharmacy’ was placed under this ‘communication’ theme. Other 
examples include, ‘confusing messaging between GP/community 
pharmacy’, and ‘no existing relationship with pharmacist’. Some 
themes and coding under barriers to use of the patient held informa-
tion included ‘too much information’, ‘burdensome to complete pull 
out [section of the patient held information], and ‘timing of [patient 
held information being delivered].
Some patients found this process more challenging. Sharing 
knowledge facilitated the framework development process. 
Patient analysts were able to ‘interchange…ideas and observations’. 
Researchers were able to facilitate discussions and convey how to 
create themes. One patient analyst felt comparing interpretations 
with older patient analysts was extremely interesting.
‘When asked to divide our findings into categories I 
was eager to start. I had several [sticky notes] that 
I thought should go in particular categories, but as I 
stepped back and looked at what others had done I 
realised there were many angles from which to inter-
pret this data. It was good to hear the thoughts and 
reasonings of the other members of the group. We 
were able to debate and have our suggestions ac-
cepted or rejected in a friendly and lively discussion. 
Listening to other perspectives and points of view has 
helped me to appreciate the many ways in which data 
can be described’.
The process enabled patient analysts to get close to data, and co- 
construct themes across multiple interviews based on their knowledge 
from lived experiences of heart failure. Through co- developing the 
framework as a group, key themes were elucidated in the discussions 
between patient analysts and researchers. Crucially, patient analysts’ 
interpretations enhanced the framework. Themes reflected the pa-
tients’ in- depth understanding of living with heart failure, embedding 
interview data within the wider experience. This helped researchers to 
understand the key reasons for patient interviewee experiences of the 
ISCOMAT intervention.
For the patient analyst unable to attend the workshop due to 
time and capacity limitations, the researchers organised a system to 
support their involvement. The patient analyst was sent: the frame-
work developed in the workshop organised into a matrix, written 
instructions, and a transcript. The instructions prompted the patient 
analyst to decide whether the framework ‘made sense’ and whether 
they could identify new themes. An example was provided, and 
they were asked to read the transcript searching for quotes, map-
ping them onto the matrix and leaving cells blank where no relevant 
quote appeared.
Without group interaction and training, this patient had diffi-
culty understanding how the framework could be developed from 
transcripts.
‘When I embarked on the coding of the transcripts, I 
initially found it quite difficult to know where to start. 
Although there were some basic instructions of what 
     |  7POWELL Et aL.
was being looked for, it was hard to know how to ap-
proach the task when faced with the transcript and 
code side by side. I initially read through the coding 
to get an idea of the areas in the transcript I was look-
ing for and then read through the transcript to see 
if the coding areas related to specific sections of the 
coding. It soon became apparent that this wasn’t the 
case, so I then went back and tried to familiarise my-
self more closely with the individual elements in the 
coding so I could identify when lines within the tran-
script matched with them. I would then write the lines 
of the transcript next to the related coding elements. 
I needed to repeat this a few times in order to feel 
confident that I hadn’t missed anything out’.
Through a process of contrasting between transcript and frame-
work, it was eventually possible to code. Modifying the predeveloped 
framework according to the transcript posed difficulties. The patient 
was unclear as to whether they could make changes. The patient coded 
the transcript and mapped on quotes, not making any alterations to 
the framework developed in the workshop. Researchers' reflected 
that they had held back on providing remote training out of concern of 
burdening the patient analyst who was working remotely with several 
documents, yet training would have enhanced the patient's ability to 
analyse data.
A framework for analysing our patient data was created, iden-
tifying key barriers and enablers to the experiences at community 
pharmacy, experience with medicines, and experience with the pa-
tient held information. It was crucial in organising data and enabling 
researchers to develop further interpretations. Such knowledge 
helped in developing a critical understanding of interviewees expe-
riences with the intervention.
Step five: Applying the analytical framework.
The researchers analysed the remaining 15 patient transcripts. 
All 20 interviews were indexed according to the co- analysed frame-
work. Qualitative data analysis software NVivo 1223 was used for 
this process. The researchers felt the co- developed framework 
worked well. Only minor alterations to the framework were made 
in light of new transcripts and internal discussions. Patient analysts 
were not involved in step five.
Step six: Charting data into the framework matrix.
The researchers summarised the 20 transcripts according to key 
themes identified. The summaries were displayed in a matrix using 
NVivo 12.23 The display facilitated the interpretation of the data at 
step seven, as well as enabling the researchers to rapidly make con-
nections between the summaries and the original coded transcripts. 
The process evaluation team checked the quality and consistency of 
the summaries. Patient analysts were not involved in step six.
Step seven: Interpretation.
Researchers, the wider process evaluation team and patient 
analysts were involved in step seven. The researchers conducted 
descriptive and explanatory analysis. Patient analysts commented 
on the interpretations. This process enhanced the trustworthiness 
of findings, through establishing the transferability of data.24 Due 
to the restrictions imposed by COVID- 19, patient analysts and re-
searchers could not meet face to face. Virtual small group and in-
dividual meetings were organised via phone and a preferred online 
platform (Microsoft Teams). Patient analysts had met with research-
ers remotely for regular meetings prior to the interpretation. One 
patient who had a technical difficulty was supported through dis-
cussions about how to use the technology; however, patient ana-
lysts had IT literacy. An interpretation document was circulated in 
advance. With permission, discussions were recorded, and written 
notes taken. Further written feedback was provided via email, en-
abling reflection before, during and after the discussion. Patient an-
alysts commented on the findings, mapping their own experiences 
on to the analysis. These insights contextualised the interpretation, 
giving a deeper nuanced meaning. The experience helped patient an-
alysts understand the full process of qualitative analysis.
4  | DISCUSSION
We developed a process for involving patients as qualitative ana-
lysts. A framework was co- designed, which enabled researchers 
to index and interpret all further interview data. Patient analysts 
checked the trustworthiness of the interpretations, a process advo-
cated by Lincoln and Guba (1985).24 The process followed the stages 
of framework analysis, with patients involved in familiarisation, cod-
ing, creating a framework and interpretation. Group working was 
crucial for co- designing the framework.
The scientific value of patient involvement in research has often 
been overshadowed, with a focus on patients' experiences.7 We have 
identified the value of patient analysts for a process evaluation of a 
large- scale cluster randomised control trial of a health- care interven-
tion. Patient analysts were able to enhance researchers understanding 
of how the intervention was experienced, providing vital context. This 
was achieved through moving beyond surface level explanations, fo-
cusing on detail and context, generating meaning from the interview 
transcripts.25 The process brought patient analysts closer to data, prior 
to interpretations. The process evaluation, aimed to consider interven-
tion implementation, and how it could be used and sustained across 
different settings. Patient analysts enhanced this understanding.
Sustaining relationships between patients and researchers 
throughout a project can support patient involvement. Hoddinott26 
highlights the distinction between ‘partnership’, ‘involvement’ and 
‘participating’, where ‘participants’ are the subject of the research, 
those ‘involved’ work with researchers or in ‘partnership’ as hav-
ing an on- going relationship with trust respect and an equal voice. 
Debates that took place in the workshop were facilitated due to ex-
isting relationships, while also enhancing them. Moreover, patients 
had in- depth knowledge of ISCOMAT having been involved in it pre-
viously, enabling them to focus purely on the data analysis process. 
Building up relationships and trust at the earlier phases of research 
projects can make a critical difference to the analysis process. Group 
working and existing relationships prevented a tokenistic approach.
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PPI needs to be flexible to each research project.13 Patients can 
be upskilled in research through relevant training, supporting their 
meaningful involvement.12 Our face- to- face approach enabled pa-
tients to code data and develop a framework with a relatively short 
training component. Patient analysts’ and researchers’ knowledge 
was shared through the process. The framework method enabled 
multiple and less research experienced analysts to code data.20 
Some projects have developed more intensive methods for patient 
analysts in their analysis process, through for example, running mul-
tiple workshops.5 However, such an intensive approach may not 
be appropriate for patients involved in all projects. Involvement 
needs to consider appropriateness for patients, ensuring they can 
contribute how and when they choose to do so.27 Enabling patients 
to be involved in a meaningful way in large- scale projects is crucial. 
However, there is limited research that has considered how to effec-
tively involve patients as co- analysts in a complex process evaluation 
of a large- scale cluster randomised control trial. The ISCOMAT pa-
tients living with heart failure, who may not be well enough on any 
given day, or have other commitments, may have had difficulty in 
committing to a more intensive process. The process we developed 
reflected patients’ needs, the research design of the ISCOMAT pro-
gramme, and was adapted due to COVID- 19. Patient analysts were 
able to continue the process remotely given their relatively high 
educational background and IT literacy. However, patient analysts 
stressed that they did not have previous qualitative analysis expe-
rience, nor academic backgrounds. Replicating this analysis process 
may not be possible with those with low educational background, 
and/or lacking access to and ability with information technology.
A key strength has been the enhancement of our patient anal-
ysis, with the co- designed framework informing all further patient 
data analysis. All patients valued the opportunity to become ana-
lysts. One patient commented that, ‘personally, I feel that this expe-
rience was the most interesting and rewarding part of the study…I 
would very much like to be part of workshops like this in future proj-
ects’. However, our process had limitations. The one- day training 
and workshop was tiring for some. The team could have explored 
ways of facilitating patients to develop the mindset for analysis 
prior to a workshop. Training could have been provided through a 
recording of the initial presentation, group working and meeting 
together after. Researchers felt that the training needed to occur 
before the coding process and were concerned with burdening pa-
tients. Any concerns about burdening patients, however, should be 
discussed with patients themselves. For example, researchers held 
back on sending extensive information for the patient analyst work-
ing remotely as they felt too much information could be onerous. 
However, this patient analyst felt they needed more information to 
analyse the data. They also felt they would have gained more from 
group interaction and would have understood more of the analysis 
process. We would therefore recommend creating at least some op-
portunity for group members to interact, particularly in developing 
a framework. Methods could perhaps explore asynchronous group 
interactions if patients are unable to meet at one time. The patient 
analyst working remotely suggested holding a group plenary session 
with other patient analysts and researchers, after coding. This would 
have provided validation that they had completed the exercise cor-
rectly. The researchers felt that discussing analysis process plans 
more in advance could have improved patient analysts experience. 
However, patient analysts were satisfied with their involvement in 
analysis plans.
5  | CONCLUSION
We have developed a method for involving patients as analysts of 
qualitative data in a process evaluation. The method involved a com-
bination of a one- day workshop involving a short training component 
and home working. The process enabled key themes to be co- 
constructed in discussions between patient analysts and research-
ers, creating a framework for the analysis of all further patient data. 
The approach taken enabled the process evaluation team to learn 
from patients to gain a deeper understanding of the implementation 
and transferability of an intervention. We were able to learn what 
are the barriers and facilitators to use of patient held information, 
experiences with community pharmacy and medicines experience.
We suggest the process as an example for analysis of qualitative 
data in complex process evaluations of clinical trials. Developing a rig-
orous process which meaningfully involves patient analysts is crucial 
for the research to hold scientific value. Key considerations around 
patient and researcher group dynamics, and research design needs 
to be made clear when selecting the process. Researchers should 
not only contact patients when they require help. Relationships be-
tween researchers and patients need to be built prior to an analysis 
process, with constant engagement, keeping up to date and devel-
oping rapport throughout the project's lifespan. Shorter projects 
would need to develop methods to build relationships in a limited 
timescale; which might be achieved through more meetings, emails 
and communication.
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